12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Other News

F2G, University of Manchester infectious news

Antifungal company F2G and the university began the €6.1 million ($8 million) NOFUN project to discover and develop antifungal drugs to treat serious, life-threatening...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >